Tech Company Financing Transactions
EBPI Merger Funding Round
On 3/31/2016, EBPI Merger raised funding from InterWest Partners.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2155 Park Blvd.
Palo Alto, CA 94306
USA
Palo Alto, CA 94306
USA
Phone
Website
Email Address
Overview
Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of Orphan diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Cory
Chief Financial Officer
Sri Ryali
VP - Bus. Development
James Shaffer
VP - General Counsel
Stephana Patton
VP - Operations
Ingrid Choong
VP - Regulatory Affairs
Matthew Bryant
VP - Regulatory Affairs
Richard Franco
Browse more venture capital transactions:
Prev: 3/31/2016: Greycork venture capital transaction
Next: 3/31/2016: Index Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs